Opko Health Inc Azioni (OPK) Dati Finanziari
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues | 60.01%65.41 | 163.58 | 124.20 | 148.45 | 151.67 |
| Cost Of Revenue | 72.06%23.35 | 83.56 | 78.44 | 84.43 | 101.78 |
| Gross Profit | 47.43%42.06 | 80.02 | 45.76 | 64.03 | 49.89 |
53.07%24.84 | 52.92 | 48.61 | - | - | |
| Selling, General, and Administrative | 53.07%24.84 | 52.92 | 48.61 | - | - |
| Research and Development | 2.98%32.18 | 33.17 | 29.20 | - | - |
| Costs And Expenses | 43.23%96.82 | 170.55 | 175.21 | 186.77 | 103.61 |
| Depreciation and Amortization | 18.94 | - | - | - | - |
| Operating Income/Loss | 350.50%-31.41 | -6.97 | -51.02 | -38.32 | 48.06 |
| Nonoperating Income/Loss | 0.47%-6.46 | -6.43 | -9.94 | -8.58 | -6.63 |
| Income/Loss From Equity Method Investments | -5.00 | - | -0.00 | -0.02 | -0.00 |
| Income/Loss From Continuing Operations Before Tax | 219.92%-42.87 | -13.40 | -60.96 | 148.45 | 41.43 |
| Income Tax Expense/Benefit, Deferred | 60.42%-10.05 | -6.27 | -7.89 | -10.15 | 18.29 |
| Income Tax Expense/Benefit | 46.70%-7.31 | -4.98 | -6.11 | -15.66 | 19.80 |
| Income/Loss From Continuing Operations After Tax | -35.56 | - | - | -31.26 | 21.63 |
| Income/Loss From Discontinued Operations, Net Of Tax | -17.98 | - | - | - | - |
536.10%-53.53 | -8.42 | -54.85 | -31.26 | 21.63 | |
| Attributable To Parent | 536.10%-53.53 | -8.42 | -54.85 | -31.26 | 21.63 |
| Basic Average Shares | 1.16%746.48 | 755.27 | 758.88 | 5.00 | 777.15 |
| Diluted Average Shares | 1.16%746.48 | 755.27 | 758.88 | 5.00 | 779.92 |
| Basic Earnings Per Share | 600.00%-0.07 | -0.01 | -0.07 | -0.04 | 0.03 |
| Diluted Earnings Per Share | 600.00%-0.07 | -0.01 | -0.07 | -0.04 | 0.03 |